NDAORAL-21TABLETPriority Review
Approved
Apr 1968
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OVRAL is an oral contraceptive containing ethinyl estradiol and norgestrel, two synthetic hormones that prevent ovulation and thicken cervical mucus to inhibit sperm penetration. It is indicated for pregnancy prevention in women of reproductive age. The combination of estrogen and progestin works by suppressing the luteinizing hormone surge necessary for ovulation.
LOE Approaching
As a legacy contraceptive approaching loss of exclusivity with moderate competitive pressure (30/100), OVRAL brand team is likely small and focused on retention strategies rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OVRAL as a legacy oral contraceptive offers limited growth potential and smaller team scope compared to growth-stage products, but provides valuable experience in mature market management, generic competition strategy, and defending market share in a commoditized therapeutic class. This role is best suited for professionals seeking stable, specialized expertise in contraceptive positioning rather than career acceleration.
Brand Manager
Worked on OVRAL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.